Sarcoma represents just 1% of all adult cancers. As a result, progress in sarcoma research and treatment development has been slower than in more common cancer types but sarcoma sufferers still require treatment and care. This means the need for increased funding in sarcoma research has never been higher. Research at The Royal Marsden includes participating in:

 

  • World-leading sarcoma treatment and research
  • New approaches in sarcoma: classification and treatment  and quality of life for sarcoma patients
  • Latest studies in sarcoma: genetic risk  International Kindred Study (ISKS)  

The Royal Marsden Research Fund Updates